OUR MISSION

PineTree Therapeutics Inc. is a preclinical stage Biotechnology company that is pioneering the development of disruptive therapies in Oncology and Other Diseases.

OUR SCIENCE 

AbReptor is a first and best-in-class, transformative and modular bi-specific and multi-specific antibody platform designed to degrade membrane-bound and extracellular proteins.

​Our TAER-TAB technology is a bispecific antibody (bsAb) platform that targets a unique but difficult-to-target receptor that is present on cancer cells in many types of cancers such as Lung, Breast, Pancreatic, Cervical, Colon, Kidney, Ovarian, Stomach etc.

OUR TEAM

PineTree Tx brings together a team of accomplished Scientific and Business Leaders with compelling track record of drug discovery, development and commercialization to create targeted Biologic therapeutics for unmet needs in Oncology and other diseases.

Meet the Team

OUR INVESTORS

---

Contact Us Today